Journal of Korean Dental Science

Korean Academy of Dental Science (대한치의학회)
권호 표지
DOI QR코드

DOI QR Code

Application of Diagnostic Laboratory Tests in the Field of Oral Medicine: A Narrative Review

  • Ji Woon, Park (Department of Oral Medicine and Oral Diagnosis, School of Dentistry and Dental Research Institute, Seoul National University) ;
  • Yeong-Gwan, Im (Department of Oral Medicine, Dental Science Research Institute, School of Dentistry, Chonnam National University)
  • Received : 2022.11.29
  • Accepted : 2022.12.08
  • Published : 2022.12.30
Download PDF
⟨ Previous Next ⟩

Abstract

The purpose of laboratory tests in the field of oral medicine can be divided into two categories: (1) medical evaluation of patients with systemic diseases that are planning to receive dental care and (2) diagnosis of patients with certain oral diseases. First, laboratory tests are commonly used to evaluate patients with systemic diseases who need dental management. A combination of multiple tests is usually prescribed as a test panel to diagnose and assess a specific disease. Test panels closely related to oral medicine include those for rheumatoid arthritis, connective tissue disease/lupus, liver function, thyroid screening, anemia, and bleeding disorders. Second, laboratory tests are used as auxiliary diagnostic methods for certain oral diseases. They often provide crucial diagnostic information for infectious diseases caused by bacteria, fungi, and viruses that are associated with pathology in the oral and maxillofacial regions. Laboratory tests for infectious diseases are composed of growth-dependent methods, immunologic assays, and molecular biology. As the field develops, further application of laboratory tests, including synovial fluid analysis in temporomandibular joint disorders, salivary diagnostics, and hematologic biomarkers associated with temporomandibular disorders and orofacial pain conditions, is currently under scrutiny for their reliability as diagnostic tools.

Keywords

References

  1. Korean Society for Laboratory Medicine. Laboratory medicine. 5th ed. Seoul: PanMun Education; 2014.
  2. Solberg HE. International Federation of Clinical Chemistry (IFCC), scientific committee, clinical section, expert panel on theory of reference values, and International Committee for Standardization in Haematology (ICSH), standing committee on reference values. Approved Recommendation (1986) on the theory of reference values. Part 1. The concept of reference values. J Clin Chem Clin Biochem. 1987; 25: 337-42.
  3. Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H, Vitali C, Bowman SJ, Mariette X; International Sjogren's Syndrome Criteria Working Group. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjogren's syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol. 2017; 69: 35-45. https://doi.org/10.1002/art.39859
  4. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Menard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovsky J, Wolfe F, Hawker G. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010; 62: 2569-81. https://doi.org/10.1002/art.27584
  5. Vanderpump MP. The epidemiology of thyroid disease. Br Med Bull. 2011; 99: 39-51. https://doi.org/10.1093/bmb/ldr030
  6. Dayan CM. Interpretation of thyroid function tests. Lancet. 2001; 357: 619-24. https://doi.org/10.1016/S0140-6736(00)04060-5
  7. Soh SB, Aw TC. Laboratory testing in thyroid conditions - pitfalls and clinical utility. Ann Lab Med. 2019; 39: 3-14. https://doi.org/10.3343/alm.2019.39.1.3
  8. Kundrapu S, Noguez J. Laboratory assessment of anemia. Adv Clin Chem. 2018; 83: 197-225. https://doi.org/10.1016/bs.acc.2017.10.006
  9. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014; 37(Suppl 1): S81-90. https://doi.org/10.2337/dc14-S081
  10. Premkumar M, Anand AC. Overview of complications in cirrhosis. J Clin Exp Hepatol. 2022; 12: 1150-74. https://doi.org/10.1016/j.jceh.2022.04.021
  11. Burke MD. Liver function: test selection and interpretation of results. Clin Lab Med. 2002; 22: 377-90. https://doi.org/10.1016/S0272-2712(01)00002-6
  12. Mayer TK, Vargas RL, Knebel AE, Williams SA, Culver SP, Clark DM, King LR. Hepatitis B assays in serum, plasma and whole blood on filter paper. BMC Clin Pathol. 2012; 12: 8. https://doi.org/10.1186/1472-6890-12-8
  13. Maness DL, Riley E, Studebaker G. Hepatitis C: diagnosis and management. Am Fam Physician. 2021; 104: 626-35.
  14. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N, Eknoyan G. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005; 67: 2089-100. https://doi.org/10.1111/j.1523-1755.2005.00365.x
  15. Kellum JA, Lameire N; KDIGO AKI Guideline Work Group. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care. 2013; 17: 204. https://doi.org/10.1186/cc11454
  16. Jellinger PS, Handelsman Y, Rosenblit PD, Bloomgarden ZT, Fonseca VA, Garber AJ, Grunberger G, Guerin CK, Bell DSH, Mechanick JI, Pessah-Pollack R, Wyne K, Smith D, Brinton EA, Fazio S, Davidson M. American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for management of dyslipidemia and prevention of cardiovascular disease. Endocr Pract. 2017; 23(Suppl 2): 1-87.
  17. Hostetter AL. Screening for dyslipidemia. Practice parameter. Am J Clin Pathol. 1995; 103: 380-5. https://doi.org/10.1093/ajcp/103.4.380
  18. Neville BW, Damm DD, Allen CM, Chi AC. Oral and maxillofacial pathology. 4th ed. St. Louis: Elsevier; 2016.
  19. Madigan MT, Martinko JM, Stahl DA, Clark DP. Brock biology of microorganisms. 13th ed. San Francisco: Benjamin Cummings; 2012. p. 878-910.
  20. Kim JH, Ahn JM. Clinical characteristics of patients with oral candidiasis. J Oral Med Pain. 2021; 46: 33-40. https://doi.org/10.14476/JOMP.2021.46.2.33
  21. Freer G, Pistello M. Varicella-zoster virus infection: natural history, clinical manifestations, immunity and current and future vaccination strategies. New Microbiol. 2018; 41: 95-105.
  22. Ahn KH, Ji HJ, Kim OJ, Kim BG, Im YG. Oral syphilis responds to topical antibiotic therapy but still needs definitive systemic treatment. J Oral Med Pain. 2018; 43: 21-5.
  23. Sun S, Zhong B, Li W, Jin X, Yao Y, Wang J, Liu J, Dan H, Chen Q, Zeng X. Immunological methods for the diagnosis of oral mucosal diseases. Br J Dermatol. 2019; 181: 23-36. https://doi.org/10.1111/bjd.17589
  24. Schmidt E, Rashid H, Marzano AV, Lamberts A, Di Zenzo G, Diercks GFH, Alberti-Violetti S, Barry RJ, Borradori L, Caproni M, Carey B, Carrozzo M, Cianchini G, Corra A, Dikkers FG, Feliciani C, Geerling G, Genovese G, Hertl M, Joly P, Meijer JM, Mercadante V, Murrell DF, Ormond M, Pas HH, Patsatsi A, Rauz S, van Rhijn BD, Roth M, Setterfield J, Zillikens D, C Prost, Zambruno G, Horvath B, Caux F. European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part II. J Eur Acad Dermatol Venereol. 2021; 35: 1926-48. https://doi.org/10.1111/jdv.17395
  25. Rashid H, Lamberts A, Diercks GFH, Pas HH, Meijer JM, Bolling MC, Horvath B. Oral lesions in autoimmune bullous diseases: an overview of clinical characteristics and diagnostic algorithm. Am J Clin Dermatol. 2019; 20: 847-61.
  26. Hayakawa T, Furumura M, Fukano H, Li X, Ishii N, Hamada T, Ohata C, Tsuruta D, Shimozato K, Hashimoto T. Diagnosis of oral mucous membrane pemphigoid by means of combined serologic testing. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014; 117: 483-96. https://doi.org/10.1016/j.oooo.2013.12.402
  27. International classification of orofacial pain, 1st edition (ICOP). Cephalalgia. 2020; 40: 129-221. https://doi.org/10.1177/0333102419893823
  28. Clark GT, Dionne R. Orofacial pain: a guide to medications and management. 1st ed. Chichester: WileyBlackwell; 2012. p. 236.
  29. Morr Verenzuela CS, Davis MDP, Bruce AJ, Torgerson RR. Burning mouth syndrome: results of screening tests for vitamin and mineral deficiencies, thyroid hormone, and glucose levels-experience at Mayo Clinic over a decade. Int J Dermatol. 2017; 56: 952-6. https://doi.org/10.1111/ijd.13634
  30. Bouloux GF. The use of synovial fluid analysis for diagnosis of temporomandibular joint disorders. Oral Maxillofac Surg Clin North Am. 2018; 30: 251-6. https://doi.org/10.1016/j.coms.2018.03.001
  31. Kaneyama K, Segami N, Sun W, Sato J, Fujimura K. Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005; 99: 276-84. https://doi.org/10.1016/j.tripleo.2004.06.074
  32. Nam Y, Kim YY, Chang JY, Kho HS. Salivary biomarkers of inflammation and oxidative stress in healthy adults. Arch Oral Biol. 2019; 97: 215-22. https://doi.org/10.1016/j.archoralbio.2018.10.026
  33. Kim HI, Kim YY, Chang JY, Ko JY, Kho HS. Salivary cortisol, 17β-estradiol, progesterone, dehydroepiandrosterone, and α-amylase in patients with burning mouth syndrome. Oral Dis. 2012; 18: 613-20. https://doi.org/10.1111/j.1601-0825.2012.01937.x
  34. Kim JR, Jo JH, Chung JW, Park JW. Antinuclear antibody and rheumatoid factor positivity in temporomandibular disorders. Head Face Med. 2018; 14: 26. https://doi.org/10.1186/s13005-018-0183-3
  35. Son C, Park YK, Park JW. Long-term evaluation of temporomandibular disorders in association with cytokine and autoantibody status in young women. Cytokine. 2021; 144: 155551. https://doi.org/10.1016/j.cyto.2021.155551
  36. Park S, Kim JR, Jo JH, Park JW. Clinical and hematologic characteristics of temporomandibular disorders patients. J Oral Med Pain. 2018; 43: 41-51. https://doi.org/10.14476/JOMP.2018.43.2.41
  37. Park S, Jo JH, Kim YK, Park JW. Hematological biomarkers of systemic inflammation in genuine (physiologic and pathologic) halitosis. J Breath Res. 2022; 16: 036009. https://doi.org/10.1088/1752-7163/ac788d
  38. Lee BM, Park JW, Jo JH, Oh B, Chung G. Comparative analysis of the oral microbiome of burning mouth syndrome patients. J Oral Microbiol. 2022; 14: 2052632. https://doi.org/10.1080/20002297.2022.2052632